rejoy-heath-logo
    FeaturesPricing
Request a Demo
rejoy-heath-logo
    FeaturesPricing
Request a Demo
rejoy-heath-logo
Company

Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.

Contact
Click here to
Contact Support
on WhatsApp

600 California St,

San Francisco, CA 94108

hello@rejoyhealth.com
Use cases
Generate Clinical NotesWrite Patient HandoutsAnswer Patient CallsSchedule AppointmentsAsk for EvidenceSuggest LabsResearch a TopicExplore Medical KnowledgePrepare for MOC ExamsWrite Home Care Instructions
Resources
ResourcesQuestion BankContestsCommunityBlogsSearch SymptomsSearch CalculatorsSearch DrugsSymptom CheckerPricing
Term and Conditions
Privacy policyTerms of Service
Published on July 30, 2026

More Than 12 Million Eye Drops Recalled in the US Over Sterility Concerns

Editor's Choice · Picked by the Rejoy Team

Overwhelmed by health stress? Start building better health and longevity today.

Free weekly yoga and meditation challenges on American Baba. Check in daily, compete on the leaderboard, and win prizes.

Join now

Millions of over the counter eye drop products are being recalled across the United States after concerns emerged about product sterility during manufacturing. While no injuries or illnesses have been reported in connection with the recall, health experts say consumers should take the notice seriously because sterile eye products must meet strict safety standards.

The recall affects approximately 12 million cartons of several eye drop products sold under the Rohto brand. According to information published by the U.S. Food and Drug Administration (FDA), the products were recalled because there was a lack of assurance that they remained sterile during the manufacturing process.

Although this does not confirm that the products are contaminated, the issue raises enough concern for regulators and the manufacturer to remove the products from distribution while the matter is investigated.

Why Sterility Matters for Eye Drops

Unlike many other over the counter medications, eye drops come into direct contact with one of the body's most sensitive organs. Sterility is essential because even small amounts of bacteria, fungi, or foreign particles could increase the risk of eye irritation or infection.

If contaminated eye drops are used, people could experience symptoms such as:

  • Eye redness
  • Pain or discomfort
  • Excessive tearing
  • Blurred vision
  • Swelling around the eye
  • Increased sensitivity to light

In more serious cases, contaminated products could contribute to severe eye infections that may require medical treatment. Prompt medical attention is recommended if symptoms develop after using any recalled product.

Which Eye Drops Are Included?

The recall includes six over the counter eye drop products sold under the Rohto brand:

  • Rohto Cooling Eye Drops ALL-IN-ONE
  • Rohto Max Strength
  • Rohto Optic Glow
  • Rohto Digi Eye
  • Rohto Dry Aid
  • Rohto Cool Relief

The affected products were sold throughout the United States in small 0.4 fluid ounce bottles. Packaging varied by product, with bottle caps appearing in blue, green, red, or black. Some versions were also available in twin packs.

Consumers should review the lot numbers and expiration dates listed on the FDA recall notice to determine whether their purchase is affected.

Why Was the Recall Issued?

The FDA classified the action as a Class II recall, which generally indicates that using the product could result in temporary or medically reversible health effects. A Class II recall does not necessarily mean that contamination has been confirmed. Instead, it reflects a potential risk that warrants removal from the market.

In this case, the manufacturer cited a lack of assurance of sterility. This means quality control procedures could not fully verify that every affected product met the required sterile standards.

The manufacturer has not announced any confirmed contamination, and there have been no reports of injuries linked to these products at the time of publication.

What Should Consumers Do?

Anyone who has recently purchased one of the recalled eye drops should check whether the product matches the recall information.

If it does, consumers should:

  • Stop using the product immediately.
  • Follow the manufacturer's or retailer's return instructions if available.
  • Dispose of the product safely if instructed.
  • Contact a healthcare provider if any unusual eye symptoms develop after use.

People who experience severe pain, vision changes, discharge, or worsening redness should seek prompt medical evaluation.

Previous Eye Drop Recalls Highlight the Importance of Safety

Eye drop recalls have attracted significant attention in recent years due to several high profile contamination events.

In 2023, contaminated eye drops manufactured overseas were linked to a nationwide outbreak involving drug resistant bacteria. Multiple patients developed serious eye infections, several people experienced permanent vision loss, and a small number of deaths were reported after infections spread beyond the eye.

While the current recall is different because no contamination has been confirmed, the earlier outbreak demonstrated why manufacturers and regulators respond quickly whenever sterility questions arise.

Removing potentially affected products before confirmed illnesses occur is an important precaution that helps reduce public health risks.

Where Were the Products Sold?

The recalled eye drops were distributed nationwide in the United States through retail stores and other outlets that sell over the counter health products.

Because these eye drops are widely available, consumers should check medicine cabinets at home as well as recently purchased personal care items.

People who keep backup supplies should also verify expiration dates and lot numbers before using any unopened bottles.

Understanding FDA Recall Classifications

The FDA uses three primary recall classifications to communicate potential health risks.

Class I recalls involve products that could cause serious injury or death.

Class II recalls involve products that may cause temporary or medically reversible health problems, or where the likelihood of serious harm is considered lower.

Class III recalls involve products that are unlikely to cause adverse health effects but still violate manufacturing or labeling standards.

The current eye drop recall falls under the Class II category.

How to Use Eye Drops Safely

Regardless of whether a product has been recalled, following safe practices can help reduce the risk of infection.

Helpful tips include:

  • Wash your hands before applying eye drops.
  • Avoid touching the bottle tip to your eye or skin.
  • Replace the cap immediately after use.
  • Store products according to label instructions.
  • Never share eye drops with another person.
  • Discard products after their recommended use period once opened.

These simple steps help minimize the introduction of bacteria into the bottle.

Frequently Asked Questions

Are the recalled eye drops confirmed to be contaminated?

No. The recall was issued because sterility could not be fully assured. There has been no public confirmation that contamination has been found in the affected products.

Has anyone become ill?

At the time of writing, no illnesses or injuries associated with this recall have been reported.

Should I stop using my eye drops?

If your product is included in the recall, you should stop using it and follow the instructions provided by the manufacturer or the FDA.

Where can I check if my bottle is affected?

Consumers can compare their product's lot number and expiration date with the official recall information available on the FDA website.

Final Thoughts

Product recalls involving eye medications are taken seriously because even a small failure in sterility can pose a risk to vision. Although there is currently no evidence that these recalled products have caused harm, removing them from circulation is a precaution designed to protect consumers.

If you own any of the affected eye drops, check the recall details as soon as possible and discontinue use if your product is included. Staying informed and following official guidance can help reduce unnecessary health risks.

Source

  • U.S. Food and Drug Administration (FDA) Enforcement Report (Recall Notice)
  • Information about the recall was also reported by the Daily Mail on July 29, 2026.

Disclaimer

This article is intended for informational and educational purposes only and should not be considered medical advice. If you experience eye pain, vision changes, signs of infection, or other concerning symptoms after using any eye care product, consult a qualified healthcare professional immediately. Always rely on official guidance from the U.S. Food and Drug Administration and your healthcare provider regarding recalled medical products.

Editor's Choice · Picked by the Rejoy Team

Better health. Longer life. One day at a time.

Tired of worrying about your health without knowing what to do next? Join a free challenge on American Baba. Daily yoga or meditation check-ins, a supportive leaderboard, and prizes for top participants. Build the habits that support better overall health and longevity starting today.

Get started free

Share this post

Explore Related Articles for Deeper Insights

Papaverine Injection Recall Issued Nationwide After Glass and Chemical Contamination Detected
FDA Announces Recall of Papaverine Hydrochloride Injection Over Safety Concerns A nationwide recall...
View article →
Vietnam Performs First Successful Penis Transplant From Brain Dead Donor in Landmark Medical Breakthrough
Vietnam has reached a significant milestone in reconstructive surgery after doctors successfully per...
View article →
FDA Advisory Panel Supports Two Peptides for Pharmacy Compounding While Rejecting Another
An FDA advisory panel has recommended allowing compounding pharmacies to prepare two additional pept...
View article →

To get more personalized answers,
download now

Login
Register